HAEMONETICS CORP — Director's Dealing 2014

Jul 24, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-07-23

Reporting Person: White Jonathan (Chief Science and Technology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-23	Common Stock	D	719.0	$35.29	Disposed	25074	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.

F2: Ownership increased 627 shares that were acquired under a Section 423 employee stock purchase plan.